INJ ECULIZUMAB 300MG
Indian Army · Pharmaceuticals · awarded
Key facts
- Published: 14 Jul 2026
- Closing date: 24 Jul 2026
- Status: awarded
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of 36 units of INJ ECULIZUMAB 300MG by the Indian Army, Ministry of Defence, Department of Military Affairs. Bid validity is 180 days from the end date, with bid opening scheduled for 24-07-2026 at 10:30 AM. The tender includes details on eligibility, purchase preferences, and technical specifications.
Eligibility & requirements
- Past performance: 50%
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience and Turnover proof, OEM Authorization Certificate, Additional documents as per ATC, Compliance documents
Commercial terms
- Bid type: Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): Yes
- MSE preference: Yes
Line items (1)
- Eculizumab 300mg Injection — Qty: 36 unit
1 tender document(s) available — sign up to download.